Lp(a) Taskforce Logo

Governance & Members

Global experts and stakeholders advancing the Task Force’s mission and priorities

Meet the members of the Task Force by clicking below:
Prof. Florian Kronenberg

Chair of International Task Force

Head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck

Prof. Zanfina Ademi

Professor of Health Economics and Outcomes Research

Nicola Bedlington

Founding Partner and Director, Millwater Partners GmbH

Magdalena Daccord

Chief Executive Officer, FH Europe Foundation

Dr. Marius Geantă

President and Co-Founder, Centre for Innovation in Medicine

Dr. Tobias Silberzahn

Trained biochemist and immunologist

Prof. Albert Wiegman

Paediatric Cardiologists at Amsterdam University Medial Center

Dr. Zhenyue Chen

Cardiologist and Professor, Department of Cardiovascular Medicine

Bogi Eliasen

Director of Health, Copenhagen Institute for Futures Studies

Prof. Mariko Harada-Shiba

Professor at the Cardiovascular Center, Osaka Medical and Pharmaceutical University

Marc Rijken

Lp(a) Patient Ambassador

Prof. Raul Santos

Academic Research Organisation Einstein Hospital Israelita & University of São Paulo

Dr. George Thanassoulis

Director of Preventive and Genomic Cardiology, McGill University Health Centre

Victoria Tzouma

International Health Policy Director, Amgen

Christian Thonke

Executive Director for Portfolio Policy, Global Public Affairs, Novartis

Dr. Andrija Janićijević

Global Medical Affairs Lead Internal Medicine, Clinical Chemistry, Roche Diagnostics

Get Involved

Advancing the integration of Lp(a) into policy and practice requires coordinated action across stakeholders. The Lp(a) International Task Force invites policymakers, researchers, clinicians, and organisations to contribute to this effort by sharing expertise, supporting implementation, and strengthening the evidence base.

To explore collaboration opportunities, please contact us or register your interest via this form.

Name

Role

Bio coming soon ...